Loading provider…
Loading provider…
Hematology & Oncology Physician in Oceanside, CA
NPI: 1043673734Primary Employer
Scripps Clinic
scripps.org
HQ Phone
Get MD David's Phone Numberphone_androidMobile
Get MD David's MobileLooking to connect with more Physicians?
Dmand AI gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Get Started for Freearrow_outwardCA State Medical License
CA State Medical License
2017 - 2027

American Board of Internal Medicine
Internal Medicine

American Board of Internal Medicine
Hematology

American Board of Internal Medicine
Medical Oncology
University of Southern California/Los Angeles General Medical Center (USC/LA General)
Residency • Internal Medicine
2016 - 2019
The Robert Larner, M.D. College of Medicine
uvm.edu
Medical School
Until 2016
| # | Procedure Code (CPT®/HCPCS II) | Procedure Patients | Procedure Volume |
|---|---|---|---|
| 1 | 99204New patient office or other outpatient visit, 45-59 minutes | 278 | 278 |
| 2 | 99214Established patient office or other outpatient visit, 30-39 minutes | 273 | 669 |
| 3 | 96365Infusion into a vein for therapy, prevention, or diagnosis up to 1 hour | 157 | 259 |
| 4 | 96413Infusion of chemotherapy into a vein up to 1 hour | 124 | 368 |
| 5 | 96375Injection of different drug or substance into a vein for therapy, diagnosis, or prevention | 91 | 396 |
Detangling the Threads of Hairy Cell Leukemia, Beyond the Morphology and Into the Molecular.
Authors: Pranav Gandhi, Danielle Brazel, Alan Saven
Journal: Clin Lymphoma Myeloma Leuk
Publication Date: 2024-05-03
Multi-gene panel testing for hereditary cancer susceptibility in a rural Familial Cancer Program.
Authors: Marc Greenblatt, Marie Wood
Journal: Fam Cancer
Authors: Ilene Weitz, Anastasia Martynova, Victor Chiu
Journal: Ann Hematol
Publication Date: 2021-01-09
Lead Sponsor: Scripps Health
Intervention / Treatment: DRUG: Low dose vemurafenib plus rituximab